Encompass Health's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Encompass Health's ROA in the third quarter of 2026?
Encompass Health Corporation achieved a return on average assets (ROA) of 10.93 % in its third quarter of 2026, this is above EHC's average return on assets of 9.77%.
Encompass Health Corporations assets during the 12 months ending in the third quarter of 2026 are valued at $7 billion

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 89 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 519, from total ROA ranking in the second quarter of 2026 at 620.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	12.78 %	9.9 %	10.12 %	10.05 %	9.85 %
Y / Y Net Income Change	-14.15 %	12.17 %	26.31 %	23.69 %	18.69 %
Net Income (TTM) in million	809	833	811	759	720
Return On Assets (TTM)	10.93 %	11.6 %	11.56 %	11.09 %	10.78 %
EHC's Total Ranking	# 519	# 620	# 570	# 579	# 613
Total Assets (TTM) in million	7,743	7,458	7,313	7,090	6,866
Seq. Total Assets Change	3.83 %	1.97 %	3.15 %	3.26 %	1.18 %
Seq. Net Income Change	-27.72 %	-16.44 %	22.21 %	16.32 %	-5.57 %

EHC's 5 Years Annual ROA >> Back to EHC Management Effectiveness >> Compare EHC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 5
Sector	# 90
Overall	# 553

Return On Assets Statistics
High	Average	Low
45.85 %	9.77 %	5.48 %
(Jun 30 2011)		(Sep 30 2020)

Financial Statements
Encompass Health's Assets	$ 7,743 million	EHC's Balance sheet
Encompass Health's Income	$ 150 million	Quarterly EHC's Income Statement
EHC's Income by Division		See EHC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	11.95 %	7.42 %	8.67 %	-18.1 %	6.81 %
Total Assets in million	7,090	6,333	5,895	5,425	6,624
Y / Y Net Income Change	27.24 %	28.86 %	26.54 %	-29.25 %	40.24 %
Net Income in million	759	597	463	366	517
Annual Return On Assets	10.71 %	9.42 %	7.85 %	6.74 %	7.81 %

EHC's 5 Years Annual ROA >> Back to EHC Management Effectiveness >> Compare EHC ROA to its Competitors

Comment on EHC's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 10.71 % compared to prior year, due to annual net income growth of 27.24 % to $759.10 million, while value of Encompass Health's overall assets grew just by 11.95 % to $7,089.70 million, compared to $7,089.70 a year before.

More Return On Assets Ratios
EHC's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EHC's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EHC's Competitors
Subscribers only: Roa for Encompass Health's Suppliers
Subscribers only: Return On Assets for EHC's Customers

You may also want to know
EHC's Roi	EHC's Inventory Turnover Ratio	EHC's Growth Rates	EHC's Dividend Comparisons
	EHC's Profitability Ratios	EHC's Asset Turnover Ratio	EHC's Dividend Growth
EHC's Roe	EHC's Valuation Ratios	EHC's Financial Strength Ratios	EHC's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Zevra Therapeutics Inc	26.33 %
Caredx Inc	25.74 %
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Protalix Biotherapeutics inc	19.89 %
Electromed Inc	19.73 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Alpha Pro Tech Ltd	12.46 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %

Date modified: 2026-11-04T16:48:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.